Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Nuvectis Pharma, Inc. (NVCT)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
11.76-0.19 (-1.63%)
At close: 03:59PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close11.95
Open11.80
Bid4.72 x 1000
Ask18.84 x 800
Day's Range11.19 - 12.00
52 Week Range6.21 - 20.92
Volume7,272
Avg. Volume61,131
Market Cap172.123M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Nuvectis Pharma Announces Upcoming Presentations at the 2023 American Association for Cancer Research Meeting

    Fort Lee, NJ, March 17, 2023 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology, today announced upcoming presentations for NXP800 and NXP900 at the upcoming 2023 American Association for Cancer Research Meeting (2023 AACR), taking place from April 14th to April 19th in Orlando, Flori

  • GlobeNewswire

    Nuvectis Pharma to Participate in a Fireside Chat at the 35th Annual Roth Conference

    FORT LEE, NJ, March 10, 2023 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (“Nuvectis”, “Company”), a biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology, today announced that Ron Bentsur, Chairman and Chief Executive Officer, will participate in a fireside chat at the 35th Annual Roth Conference. Event 35th Annual Roth Conference Date March 14, 2023 Time 12:00 PM Pacific Time (3:00 PM Easter

  • Simply Wall St.

    Bullish insiders bet US$1.1m on Nuvectis Pharma, Inc. (NASDAQ:NVCT)

    When a single insider purchases stock, it is typically not a major deal. However, when multiple insiders purchase...

Advertisement
Advertisement